Paul Chaney joins Lux Biosciences
This article was originally published in Scrip
Executive Summary
Lux Biosciences (US) has appointed Paul Chaney to its board of directors. He is the former president of (OSI) Eyetech and executive vice-president of OSI Pharmaceuticals.